SB 260 – ConnecticutStatus: Inactive / Dead
Year Introduced: 2022
To establish a board with authority to monitor prescription drug costs and recommend price caps on such drugs sold in the state.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
No items found